Laronidase (Aldurazyme) and Iduronidase (Idursulfase) are two medications that are used to treat lysosomal storage disorders. Laronidase is used to treat mucopolysaccharidosis type I (MPS I), a rare genetic disorder that affects the body's ability to break down certain complex sugars. Iduronidase is used to treat mucopolysaccharidosis type II (MPS II), a disorder that affects the body's ability to break down complex sugar molecules, causing a buildup of harmful substances in the body. Both medications are enzyme replacement therapies that replace missing enzymes in the body, allowing the body to break down the sugars more efficiently and reduce the buildup of harmful substances.
Laronidase, also known by the brand name Aldurazyme, is a prescription medication used for a specific enzyme replacement therapy [1, 2]. Here's a breakdown of what it targets and how it works:
- Condition treated: Laronidase is used to treat symptoms of Mucopolysaccharidosis type I (MPS I), also known as Hurler syndrome, Hurler-Scheie syndrome, or Scheie syndrome [1, 2]. These are rare, inherited metabolic disorders.
- How MPS I works: In MPS I, the body lacks an essential enzyme called alpha-L-iduronidase. This enzyme is responsible for breaking down specific complex sugar molecules within cells. Without this enzyme, these sugar molecules accumulate in various tissues and organs throughout the body [2, 3].
- How Laronidase helps: Laronidase acts as a replacement for the missing enzyme. It's administered intravenously (through a vein) and works by delivering the functional enzyme to cells. Once inside the cells, Laronidase helps break down the accumulated sugar molecules, potentially improving some of the symptoms associated with MPS I [2, 3].
Benefits of Laronidase:
While Laronidase is not a cure for MPS I, it can help manage some of the symptoms, potentially improving a patient's quality of life. Here are some potential benefits:
- Improved mobility and respiratory function [2, 4].
- Reduced pain and stiffness in joints [2].
- Slowed disease progression [4].
Important things to remember:
- Laronidase is a prescription medication and should only be administered under the supervision of a qualified healthcare professional.
- It is typically administered once a week through intravenous infusion [2].
- Common side effects may include rash, infusion reaction, upper respiratory tract infection, flushing, and injection site reactions [2].
- Laronidase may interact with other medications. Be sure to tell your doctor about all the medications you are taking before starting Laronidase treatment [2].